Biomedical Catalyst details announced
By Lloyd Czaplewski, May 1 2012 08:28AM
The £180 million Biomedical Catalyst fund will see the Medical Research Council and the Technology Strategy Board working together to provide responsive and effective support for the best life science opportunities arising in the UK.
Targeting SMEs and academics working independently or in collaborations, the Catalyst will provide critical funding for feasibility studies as well as early and later stage development activities.
Chemical Biology Ventures can provide value-adding consultancy through the application process and project delivery. Please contact us to discuss how we can work with you to maximise your chance of success.
Chemical Biology Ventures News